- Home
- SYF vs ICLR Comparison
SYF vs ICLR Comparison
Compare SYF & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYF
- ICLR
- Stock Information
- Founded
- SYF 1932
- ICLR 1990
- Country
- SYF United States
- ICLR Ireland
- Employees
- SYF N/A
- ICLR N/A
- Industry
- SYF Finance: Consumer Services
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- SYF Finance
- ICLR Health Care
- Exchange
- SYF Nasdaq
- ICLR Nasdaq
- Market Cap
- SYF 19.4B
- ICLR 16.4B
- IPO Year
- SYF N/A
- ICLR 1998
- Fundamental
- Price
- SYF $61.41
- ICLR $201.39
- Analyst Decision
- SYF Buy
- ICLR Strong Buy
- Analyst Count
- SYF 22
- ICLR 12
- Target Price
- SYF $66.45
- ICLR $278.27
- AVG Volume (30 Days)
- SYF 4.3M
- ICLR 913.3K
- Earning Date
- SYF 01-28-2025
- ICLR 02-19-2025
- Dividend Yield
- SYF 1.63%
- ICLR N/A
- EPS Growth
- SYF 64.74
- ICLR 28.78
- EPS
- SYF 8.55
- ICLR 9.53
- Revenue
- SYF $9,392,000,000.00
- ICLR $8,281,675,999.00
- Revenue This Year
- SYF N/A
- ICLR $4.00
- Revenue Next Year
- SYF $7.81
- ICLR $1.37
- P/E Ratio
- SYF $7.18
- ICLR $21.18
- Revenue Growth
- SYF 22.58
- ICLR 1.99
- 52 Week Low
- SYF $39.67
- ICLR $181.51
- 52 Week High
- SYF $70.93
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- SYF 33.47
- ICLR 54.92
- Support Level
- SYF $63.31
- ICLR $181.51
- Resistance Level
- SYF $65.97
- ICLR $203.26
- Average True Range (ATR)
- SYF 2.09
- ICLR 6.32
- MACD
- SYF -0.53
- ICLR 1.50
- Stochastic Oscillator
- SYF 4.72
- ICLR 72.45
About SYF Synchrony Financial
Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.